echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The future opportunities of children's medicine market will be in these three aspects

    The future opportunities of children's medicine market will be in these three aspects

    • Last Update: 2020-01-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network market analysis] in recent years, with the implementation of China's open two child policy and the superposition of environmental pollution and other issues, the rate of pediatric outpatient and emergency services in China has been high for a long time The number of pediatric outpatient and emergency services in general hospitals is growing rapidly, the age of children is getting younger and younger, and the prevalence and treatment rate are getting higher and higher According to a health statistics data in 2019, the proportion of outpatients in general hospitals in China increased from 8.22% to 9.89% in 2007-2017, and the proportion of outpatients in children aged 0-14 increased from 38.18% to 103.74% In fact, with the development of the concept and research of children's health in recent years, the demand of children's drug use is also on the rise Some research centers predict that children's medicine will maintain double-digit growth in the next five years, with a compound growth rate of about 10% in five years By 2020, the market scale of children's medicine in China is expected to exceed 110 billion yuan Facing the broad market environment of children's medicine, where will the opportunities for pharmaceutical enterprises be? New children's drug market the industry believes that in the future, with the change of disease spectrum, new children's drug market will be born In the past, children's drug use mainly focused on digestion, fever, etc., but now children's disease spectrum is also changing, including the emergence of endocrine diseases, mental diseases and other diseases, coupled with more advanced diagnosis and treatment equipment to detect the disease as soon as possible, which will surely give birth to a new market At present, some enterprises are already working towards the new market of children's medicine For example, sunflower pharmaceutical industry is carrying out research on the project of changing taste and dosage form for children's powder, oral liquid and granule medicine In addition, the research on the main indications and indications of expanded functions of key pediatric drugs is also in progress in an orderly manner In addition, a series of first European and American national drug projects for children's respiratory system diseases, digestive system diseases, nervous system diseases, etc., are under orderly research In fact, in recent years, China's pharmaceutical industry is undergoing profound changes driven by policies With the implementation of the new drug administration law, the pharmaceutical industry in China will develop towards standardization, intensification, internationalization and innovation In this environment, the subdivision field of pediatric medicine industry will also meet new opportunities and challenges The shortage of higher pharmaceutical preparations for children in China will bring new development space for innovative enterprises For children with the characteristics of clinical medication, it is an urgent need for higher preparations or will be a research and development hotspot Compared with the simple tablet, capsule or oral liquid in the past, in the future, slow and controlled-release preparations or special drug delivery routes, such as transdermal drug delivery, transpulmonary drug inhalation, oral diaphragm, etc., may be the research and development hotspot Individualized drug delivery is a new hot spot Individualized drug delivery is or will be a new hot spot in children's drug market in the future Because compared with adults, children have weaker immunity and are more likely to be infected with diseases At the same time, because the body of children is not mature, which is significantly different from that of adults, the tolerance of liver and kidney function to drug metabolism and adverse reactions is significantly different from that of adults Therefore, we should consider children's physiological characteristics fully, in many aspects and carefully when using drugs in clinical practice It is not suitable for direct use of adult drugs, and it needs individualized drug administration Therefore, this part of drug market will also be born.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.